ZEB1 and hepatocellular carcinoma: To further explore the mechanism on anti-HCC effects of HMGB1 inhibition, immunoblot analysis of EMT associated transcription factors was performed and results indicated that ZEB1 was the most downregulated in HMGB1 deficient HCC cells (Figure 6A).